COVID-19: Brazilian doctors volunteer for coronavirus vaccines

Sao Paulo: In Brazil, fitness is at the forefront of the coronavirus pandemic in more than one tactic, treating patients but also volunteering to check some of the most promising experimental vaccines.

Brazil has the highest number of infections and deaths in the pandemic, after the United States, and the virus is still spreading here.

This is bad news in every respect: it makes the South American country an ideal test floor for vaccines imaginable opposed to the virus.

The guinea pig paintings are the duty of the doctor who paints on the premises that treat patients inflamed by the virus, as they are the most likely to come into contact with the guinea pig, allowing researchers to perform a controlled experiment to see how well it is. Paintings.

“I will contribute, and this is my contribution, through science,” said pediatrician Monica Levi, one of the 5,000 volunteers in Brazil who helped verify one of the most promising vaccines to date, developed through Oxford University and pharmaceutical company AstraZeneca.

Levi, 53, works at the Specialized Clinic on Infectious and Parasitic Diseases and Immunizations (Cedipi) in Sao Paulo, the epicenter of the epidemic in Brazil, where more than 2.5 million people have become inflamed to date, with more than 90,000 deaths.

“Vaccination is my cause. So I have to act on my convictions,” he told the AFP.

Last week, Brazil was also the first country to conduct phase 3 trials of the Chinese vaccine CoronaVac, developed through the pharmaceutical company Sinovac Biotech.

Phase 3 clinical trials involve large-scale human testing, the last step before vaccines seek regulatory approval.

The medical body of workers also plays an important role in testing this vaccine.

“They are fitness care professionals because we are constantly at risk,” Levi said.

Volunteers must be between 18 and 55 years of age, paint on a patient care paper and not suffer from any underlying medical problems.

Half of the volunteers in the Oxford trial get the vaccine and the other part gets a placebo.

But they probably wouldn’t know for another year.

Levi was empted on July 21 and had a headache and chills on the first day, he said.

“But I don’t even know if I got the vaccine or the placebo,” he added.

While she hopes to know if the vaccine is coming out of the pandemic that the world expects, she will undergo tests where researchers monitor her health.

Scientists around the world are rushing to expand and oppose a vaccine to the virus. There are more than 150 projects to date.

But there is no guarantee in the race for the highest stakes.

Brazil has reached an agreement to manufacture up to one hundred million doses of the Oxford vaccine if effective.

But if not, Levi says, “everything will go to the trash.”

Dear reader,

This segment is about life in the UAE and data you can’t live without.

Sign up to read and complete gulfnews.com

Leave a Comment

Your email address will not be published. Required fields are marked *